Merit Medical ( (MMSI) ) has released its Q4 earnings. Here is a breakdown of the information Merit Medical presented to its investors.
Merit Medical Systems, Inc. is a global leader in the healthcare technology sector, specializing in the development and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures across various medical fields. The company is recognized for its innovative solutions in cardiology, radiology, oncology, critical care, and endoscopy.
Merit Medical recently reported its financial results for the fourth quarter and full year of 2024, showcasing significant growth in revenue and profitability. The company achieved a quarterly revenue of $355.2 million, marking a 9.4% increase from the previous year, while the annual revenue reached $1.357 billion, up by 7.9%. These results reflect strong operational execution and strategic acquisitions that have bolstered the company’s market position.
Key financial highlights include a notable improvement in non-GAAP operating margins, which rose to 19.6% for the quarter and 19.0% for the year. The company also reported a substantial increase in non-GAAP earnings per share, which climbed by 25.8% in the fourth quarter and 21.3% for the full year. Additionally, Merit Medical generated free cash flow of $65.3 million in the fourth quarter and $185.7 million for the year, representing an 18.4% and 67.5% increase, respectively.
Strategically, Merit Medical completed the acquisition of Cook Medical’s lead management portfolio and received FDA approval for the Wrapsody® Endoprosthesis device, enhancing its product offerings. The company also integrated the EsophyX® Z+ device into its operations, further expanding its endoscopy segment.
Looking ahead, Merit Medical has issued its financial guidance for 2025, projecting revenue growth between 8% and 10% and a non-GAAP EPS increase of 4% to 7%. The management remains confident in the company’s ability to sustain growth and profitability through continued strategic initiatives and market expansion.